PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.03%
Revenue growth above 1.5x AVGO's 3.32%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
8.75%
Gross profit growth above 1.5x AVGO's 2.36%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
73.22%
EBIT growth above 1.5x AVGO's 9.66%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
73.22%
Operating income growth above 1.5x AVGO's 9.66%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
102.27%
Net income growth above 1.5x AVGO's 6.94%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
86.84%
EPS growth above 1.5x AVGO's 6.78%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
86.84%
Diluted EPS growth above 1.5x AVGO's 8.77%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.06%
Slight or no buybacks while AVGO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
3.25%
Slight or no buyback while AVGO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
104.86%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
117.14%
Positive FCF growth while AVGO is negative. John Neff would see a strong competitive edge in net cash generation.
237.86%
10Y revenue/share CAGR above 1.5x AVGO's 21.74%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
33.74%
5Y revenue/share CAGR above 1.5x AVGO's 21.74%. David Dodd would look for consistent product or market expansions fueling outperformance.
-29.90%
Negative 3Y CAGR while AVGO stands at 21.74%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
2227.34%
10Y OCF/share CAGR above 1.5x AVGO's 49.41%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
84.38%
5Y OCF/share CAGR above 1.5x AVGO's 49.41%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
63.76%
3Y OCF/share CAGR 1.25-1.5x AVGO's 49.41%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
359.68%
Net income/share CAGR at 50-75% of AVGO's 647.30%. Martin Whitman might question if the firm’s product or cost base lags behind.
67.37%
Below 50% of AVGO's 647.30%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-36.47%
Negative 3Y CAGR while AVGO is 647.30%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
552.25%
10Y equity/share CAGR above 1.5x AVGO's 124.64%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
108.65%
5Y equity/share CAGR at 75-90% of AVGO's 124.64%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
15.59%
Below 50% of AVGO's 124.64%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.70%
Firm’s AR is declining while AVGO shows 15.09%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-8.55%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
14.80%
Asset growth above 1.5x AVGO's 7.61%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.63%
1.25-1.5x AVGO's 7.71%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
0.13%
Debt growth of 0.13% while AVGO is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
5.40%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
73.15%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.